BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

13 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Heterocyclic kinase inhibitors and uses thereofBDB
Iomx Therapeutics
NAPHTHYRIDONE COMPOUNDS FOR INHIBITION OF RAF KINASES AND/OR BCR-ABL TYROSINE KINASESBDB
Enliven
Alkynyl(hetero)aromatic compound for inhibiting protein kinase activityBDB
Shenzhen Targetrx
Alkynyl (hetero) aromatic ring compounds used for inhibiting protein kinase activityBDB
Shenzhen Targetrx
3-acetylenyl-pyrazole-pyrimidine derivative, and preparation method therefor and uses thereofBDB
St. Chuan University
Inhibitors of BCR-ABL mutants and use thereofBDB
The Regents of The University of Michigan
Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereonBDB
Obshchestvo S Ogranichennoy Otvetstvennostyou “Fusion Pharma”
Heteroaryl alkyne compound and use thereofBDB
Nanjing Sanhome Pharmaceutical
N-methyl-2-[3-((E)-2-pyridin-2-yl-vinyl)-1H-indazol-6-ylsulfanyl]-benzamide for the treatment of chronic myelogenous leukemiaBDB
Pfizer
Fused 2-aminothiazole compoundsBDB
Dana-Farber Cancer Institute
Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl purine template.BDB
Ariad Pharmaceuticals
Crystal structure of the T315I mutant of AbI kinase.BDB
Ariad Pharmaceuticals